Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Critical Reviews in Oncology/Hematology|June 6, 2006
Antisense molecules for targeted cancer therapyV Wacheck, U Zangemeister-WittkeThe Journal of Investigative Dermatology|April 20, 2000
Effects of betulinic acid alone and in combination with irradiation in human melanoma cellsE Selzer, E Pimentel, V Wacheck, et al.Molecular Medicine (Cambridge, Mass.)|October 31, 2000
A novel Ras antagonist regulates both oncogenic Ras and the tumor suppressor p53 in colon cancer cellsJ Halaschek-Wiener, V Wacheck, H Schlagbauer-Wadl, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 9, 2009
Differential role of circulating endothelial progenitor cells in cirrhotic patients with or without hepatocellular carcinomaW Sieghart, S Fellner, T Reiberger, et al.Melanoma Research|November 30, 2000
Erythropoietin receptor expression in human melanoma cellsE Selzer, V Wacheck, R Kodym, et al.The British Journal of Dermatology|January 6, 2009
Suppression of mTOR complex 2-dependent AKT phosphorylation in melanoma cells by combined treatment with rapamycin and LY294002J Werzowa, D Cejka, T Fuereder, et al.British Journal of Cancer|October 2, 2003
Bcl-x(L) antisense oligonucleotides radiosensitise colon cancer cellsV Wacheck, E Selzer, P Günsberg, et al.Journal of Molecular Medicine (Berlin, Germany)|November 3, 2001
Bcl-2 antisense oligonucleotides chemosensitize human gastric cancer in a SCID mouse xenotransplantation modelV Wacheck, E Heere-Ress, J Halaschek-Wiener, et al.European Journal of Clinical Pharmacology|May 11, 2000
Pharmacokinetics and pharmacodynamics of the novel H1-receptor antagonist emedastine in healthy volunteersB Jansen, U Graselli, S Dallinger, et al.European Journal of Clinical Investigation|March 25, 2009
Characterization of NVX-207, a novel betulinic acid-derived anti-cancer compoundM Willmann, V Wacheck, J Buckley, et al.Pageof 2